Pasithea Therapeutics Corp. KTTA
0.50
(0.01)
(1.96%)
as of 25 Sep
- Market cap
- $17.2M
- P/E
- 0.0×
Follow KTTA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | — | — |
P/S ratio |
— | — | — | 33.35 | 0.00 | — | — |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | — | — |
P/Operating CF |
— | — | — | (5.09) | (10.56) | — | — |
P/B ratio |
— | — | — | 0.38 | 0.36 | — | — |
Price to Tangible BV |
— | — | — | 0.50 | 0.36 | — | — |
EV/Sales |
— | — | — | (34.65) | 0.00 | — | — |
EV/EBITDA |
— | — | — | 1.34 | 7.64 | — | — |
EV/Operating CF |
— | — | — | 1.42 | 10.88 | — | — |
EV/FCF |
— | — | — | 1.40 | 10.81 | — | — |
Quick Ratio |
11.11 | 6.18 | 6.20 | 17.62 | 118.41 | 36.92 | — |
Current Ratio |
11.35 | 6.58 | 6.34 | 18.15 | 119.16 | 37.58 | — |
Net Debt/EBITDA |
2.74 | 0.51 | 1.07 | 2.63 | 11.75 | 5.94 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.74 | 1.00 | 0.80 | 0.85 | 1.46 | 0.94 | — |
Capex/Depreciation |
0.02 | 0.00 | 0.12 | (21.00) | (15.36) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (58.36%) | (72.83%) | (48.44%) | (29.68%) | (8.41%) | (0.16%) | — | |
| (53.54%) | (65.93%) | (44.78%) | (28.30%) | (8.11%) | (33.06%) | — | |
ROIC |
0.00% | (113.31%) | (141.31%) | (83.61%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(39.68%) | (218.26%) | (112.41%) | (43.11%) | (4.11%) | (16.98%) | — |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 547.76% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 2,039.35% | 29,835.76% | 0.00% | — |
Intangible Assets out of Total Assets |
0.06 | 0.53 | 0.35 | 0.22 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 171.62% | 8,088.08% | — | — |
Graham Net Nets |
— | — | — | 1.93 | 2.79 | — | — |
Graham Number |
— | — | — | 0.00 | 0.00 | — | — |
Earnings Yield |
— | — | — | (85.87%) | (11.80%) | — | — |
Free Cash Flow Yield |
— | — | — | (73.95%) | (17.35%) | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.39 | 0.03 | 0.00 | — |
Operating CF per Share |
(2.16) | (12.70) | (10.44) | (9.43) | (6.10) | (0.11) | — |
Capex per Share |
0.00 | 0.00 | 0.06 | (0.08) | (0.04) | 0.00 | — |
Free Cash Flow per Share |
(2.16) | (12.70) | (10.38) | (9.51) | (6.14) | (0.11) | — |
Cash per Share |
7.86 | 6.32 | 13.31 | 26.22 | 101.80 | 0.66 | — |
Shareholders Equity per Share |
7.85 | 13.49 | 19.07 | 33.68 | 98.83 | 0.66 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
7.85 | 13.49 | 19.07 | 33.68 | 98.83 | 0.66 | — |
Free Cash Flow |
(15.20) | (13.92) | (12.74) | (12.00) | (3.20) | (0.04) | — |
Working Capital |
51.49 | 6.25 | 14.06 | 32.20 | 52.85 | 0.24 | — |
Capital Expenditures |
0.01 | — | 0.08 | (0.11) | (0.02) | — | — |
Net Current Asset Value |
51.44 | 6.09 | 13.97 | 31.39 | 51.40 | 0.24 | — |
EV/EBIT |
— | — | — | 1.34 | 7.66 | — | — |
Capex to Sales |
0.00 | — | 0.00 | 0.22 | 1.42 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (2,864.06%) | (14,394.04%) | 0.00% | — |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
0.00 | 5.31 | 4.59 | 0.04 | 0.07 | — | — |
Cash ROIC |
(13.77%) | (64.71%) | (32.61%) | (15.90%) | (3.06%) | (7.98%) | — |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.12 | 0.08 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 4,776.60 | 9,437.25 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — |
Average Payables |
1.13 | 1.84 | 2.02 | 0.96 | 0.23 | 0.23 | — |
Average Assets |
38.15 | 21.09 | 35.65 | 49.25 | 26.78 | 0.12 | — |
Average Common Equity |
35.00 | 19.09 | 32.95 | 46.96 | 25.83 | 25.83 | — |
Columns are period end dates